HRT Financial
ATYR icon

HRT Financial’s aTyr Pharma ATYR Stock Holding History

HRT Financial’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75K Buy
+126,681
New +$82.7K ﹤0.01% 3685
2025
Q2 		– Sell
-182,135
Closed -$550K – 3707
2025
Q1 		$550K Buy
+182,135
New +$664K ﹤0.01% 1418

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HRT Financial's ATYR Position: Q2 2026 in Review

HRT Financial opened a new position in aTyr Pharma (ATYR) in Q2 2026: 126,681 shares worth $75K. The stake represents ﹤0.01% of the portfolio and ranks #3685 among its holdings. This is a return to the name: HRT Financial previously reported a position in ATYR as recently as Q1 2025.

HRT Financial first reported a position in ATYR in Q1 2025 and has held it in 2 quarters since. The position peaked at $550K in Q1 2025. 89 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • HRT Financial held 126,681 shares of aTyr Pharma worth $75K as of Q2 2026.
  • aTyr Pharma was a new HRT Financial position in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3685 holding.
  • HRT Financial first reported a position in aTyr Pharma in Q1 2025 and has held it in 2 quarters since.
  • HRT Financial's aTyr Pharma position peaked at $550K in Q1 2025.
  • 89 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.